Effective Screening Tool for Anal Dysplasia: Anal Pap Test, HPV Status or Co-testing?

被引:0
|
作者
Naous, Rana [1 ]
Khurana, Kamal [2 ]
机构
[1] SUNY Upstate Med Univ, Clay, NY USA
[2] SUNY Syracuse, Hlth Sci Ctr, Syracuse, NY 13210 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
454
引用
收藏
页码:164 / 164
页数:1
相关论文
共 50 条
  • [41] Assessing Urine Human Papillomavirus Polymerase Chain Reaction Testing As a Tool for Screening Anal HPV Infection in HIV-Positive MSM
    Lanoix, Jean-Philippe
    Pannier, Christine
    Borel, Alice
    El Samad, Youssef
    Robin, Christine
    Douadi, Youcef
    Woimant, Marine
    Fouche, Bernadette
    Lecaque, Caroline
    Ganry, Olivier
    Duverlie, Gilles
    Sevestre, Henri
    Schmit, Jean-Luc
    AIDS PATIENT CARE AND STDS, 2012, 26 (04) : 208 - 213
  • [42] Retrospective Analysis of HPV Infection with Co-testing and HPV Genotyping in Cervical Cancer Screening in a Large Academic Healthcare System
    Feng, Frances
    Dababneh, Melad
    Birdsong, George
    Reid, Michelle
    Hoskins, Michael
    Wang, Qun
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 254 - 256
  • [43] Pap-HPV co-testing adoption trends for cervical cancer screening in a multi-state Practice Research Network (PBRN) 2012-2017
    Shin, Michelle
    West, Imara
    Hsu, Chialing
    Prado, Maria
    Tsui, Jennifer
    Ko, Linda
    Winer, Rachel
    Cole, Allison
    ANNALS OF FAMILY MEDICINE, 2024, 22
  • [44] HPV co-testing as cervical screening test. Experience of Alweiya early detection cervical clinic: one-year analysis
    Al-Jobawi, Zainab J.
    Ali, Besmah M.
    Al-Niyazee, Asan A.
    Ibraheem, Mustafa H.
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2020, 6 (05): : 218 - 222
  • [45] Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
    Cuzick, Jack
    Du, Ruofei
    Adcock, Rachael
    Kinney, Walter
    Joste, Nancy
    McDonald, Ruth M.
    English, Kevin
    Torres, Salina M.
    Saslow, Debbie
    Wheeler, Cosette M.
    GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 555 - 559
  • [46] CLINICAL-ECONOMIC MODELING ANALYSIS OF HUMAN PAPILLOMAVIRUS (HPV) CO-TESTING WITH GENOTYPING VERSUS PRIMARY HPV TESTING FOR CERVICAL CANCER SCREENING
    Felix, J. C.
    Lacey, M. J.
    Miller, J. D.
    Lenhart, G. M.
    Kulkarni, R.
    VALUE IN HEALTH, 2015, 18 (07) : A353 - A353
  • [47] Sampling Error Is a Major Contributor to the Low Sensitivity of Anal Cytology as a Screening Tool for High Grade Dysplasia
    Pendse, A. A.
    Hertel, J. D.
    LABORATORY INVESTIGATION, 2014, 94 : 509A - 510A
  • [48] Sampling Error Is a Major Contributor to the Low Sensitivity of Anal Cytology as a Screening Tool for High Grade Dysplasia
    Pendse, A. A.
    Hertel, J. D.
    MODERN PATHOLOGY, 2014, 27 : 509A - 510A
  • [49] Without mandatory high-risk HPV co-testing, are we inadequately screening for adenocarcinoma of the cervix?
    Kahn, Ryan
    Badiner, Nora
    Nicholson, Nadine
    Cantillo, Evelyn
    Gordhandas, Sushmita
    Thomas, Charlene
    Siddiqui, Momin
    Holcomb, Kevin
    Frey, Melissa
    Chapman-Davis, Eloise
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S336 - S336
  • [50] The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results
    Bondi Volpini, Lays Paula
    Tosato Boldrini, Neide Aparecida
    de Freitas, Luciana Bueno
    Miranda, Angelica Espinosa
    Spano, Liliana Cruz
    PLOS ONE, 2017, 12 (04):